Arquivamento - Art. 36 §1° da LPI
#11.2
12/03/2024
RPI 2813
Application data
Number
112020023136Type
Filing
Publication
PCT
US2019032295 Patent grant document available
We have the complete official document for this filing, as published by INPI.
Access the documentThe application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.
Applicants
NUVATION BIO INC.
US
Inventors
A. N. (pessoa física)
IN
A. B. (pessoa física)
IN
D. H. (pessoa física)
US
J. K. (pessoa física)
US
J. C. (pessoa física)
US
S. C. (pessoa física)
US
S. P. (pessoa física)
US
IPC Classification
Priority claims
US
62/671,382 · 05/14/2018
Abstract
"COMPOSTOS DE ALVO DE RECEPTOR DE HORMÔNIO NUCLEAR ANTICÂNCER".A presente invenção refere-se a compostos anticâncer derivados de ligantes do receptor de esteroide nuclear, a produtos contendo os mesmos, bem como a métodos de seu uso e preparação.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
12/03/2024
RPI 2813
#6.23
08/13/2024
RPI 2797
#15.35
12/14/2021
RPI 2658
#1.3
02/09/2021
RPI 2614
#1.1
11/24/2020
RPI 2603
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.